Table 1 Timing of clinical trials and FDA approval for selected targeted therapies

Maxwell, K. N. & Domchek, S. M. (2012) Cancer treatment according to BRCA1 and BRCA2 mutationsNat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.123